Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf tm1Kcam

Skeletal Muscle

Volumn 5, Issue 1, 2015, Pages

  Wiktorowicz, Tatiana ^a   Kinter, Jochen ^a   Kobuke, Kazuhiro ^b   Campbell, Kevin P ^b   Sinnreich, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Dysferlin mouse models; Dysferlinopathies; Genotyping protocol; Knock out; Targeted deletion

Indexed keywords

EID: 84944032046     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/s13395-015-0057-3     Document Type: Article

References (12)

1. Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, et al. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet. 2004;13(18):1999-2010. doi: 10.1093/hmg/ddh212.
2. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, et al. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet. 1999;23(2):141-2. doi: 10.1038/13770.
3. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003;423(6936):168-72.
4. Barnabei MS, Metzger JM. Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts. PLoS One. 2012;7(3), e32880. doi: 10.1371/journal.pone.0032880.
5. Han R, Frett EM, Levy JR, Rader EP, Lueck JD, Bansal D, et al. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest. 2010;120(12):4366-74. doi: 10.1172/JCI42390.
6. Han R, Rader EP, Levy JR, Bansal D, Campbell KP. Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skelet muscle. 2011;1(1):35. doi: 10.1186/2044-5040-1-35.
7. Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, et al. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest. 2007;117(7):1805-13. doi: 10.1172/JCI30848.
8. Spector I, Zilberstein Y, Lavy A, Genin O, Barzilai-Tutsch H, Bodanovsky A, et al. The involvement of collagen triple helix repeat containing 1 in muscular dystrophies. Am J Pathol. 2013;182(3):905-16. doi: 10.1016/j.ajpath.2012.11.004.
9. Turk R, Sterrenburg E, van der Wees CG, de Meijer EJ, de Menezes RX, Groh S, et al. Common pathological mechanisms in mouse models for muscular dystrophies. FASEB j: official publication of the Federation of American Societies for Experimental Biology. 2006;20(1):127-9. doi: 10.1096/fj.05-4678fje.
10. de Lamballerie X, Chapel F, Vignoli C, Zandotti C. Improved current methods for amplification of DNA from routinely processed liver tissue by PCR. J Clin Pathol. 1994;47(5):466-7.
11. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991;10(4):506-13.
12. Han R, Kobuke K, Anderson M, Beltrán-Valero de Bernabé D, Kobayashi Y, Yang B et al. Improved genotyping of the dysferlin null mouse. Nature Publishing Group. 2011. http://dx.doi.org/10.1038/protex.2011.232.